Setbacks in the quest for universal health coverage in Mexico: polarised politics, policy upheaval, and pandemic disruption

2024 United States Elections: Air Pollution, Neurodegeneration, Neuropsychiatric, and Neurodevelopmental Disorders. Who Cares?

“…AD, PD, and TDP43 hallmarks in children have ushered a major evolving, difficult and yet unsolved health crisis of unprecedented magnitude in Mexico, with a current underprovided health infrastructure imposing serious limitations to an utterly progressively deficient health system [ 41 ] failing to protect its young vulnerable citizens.…”

HIV-1 transmission dynamics among people who inject drugs on the US/Mexico border during the COVID-19 pandemic: a prospective cohort study

“… 14 , 15 , 30 During the pandemic in Tijuana, government sponsored housing and methadone were temporarily provided only to people who inject drugs with COVID-19 symptoms, and non-COVID-19 related medical care was inaccessible. 15 Several policies had already decreased funding to civil organizations 31 and the public healthcare system, 32 which contributed to a massive disruption in providing healthcare services in the face of the pandemic. In addition, reduced tourism from the U.S. and lockdowns drastically reduced income opportunities among people who inject drugs in Tijuana, which might have further limited access to sterile syringes and led to higher frequency of syringe sharing.…”

Securing access to a comprehensive diagnostic panel for children with suspected acute lymphoblastic leukemia: Results from the Mexico in Alliance with St. Jude “Bridge Project”

“…In 2004, Mexico pioneered financing innovations to respond to the increasing burden of childhood cancers among low-income families through the Fund for Protection Against Catastrophic Expenditures (“ Seguro Popular ”) ( 6 ). The program provided coverage for ALL starting in 2005, expanded to all childhood cancers by 2007, and accredited about 55 national hospitals to care for these children nationwide ( 7 ).…”

“…The 5-year state-specific survival for children with ALL ranged from 43.7% to 74.7% throughout the country ( 9 ). Bottlenecks, inequities, and variations in quality across pediatric cancer centers prevailed, and rigidities in payment systems and treatment guideline accreditation delayed the adoption of innovations and hindered patient-centered, multi-site collaboration ( 6 , 10 ). While Seguro Popular was specifically launched for the uninsured population, similarly low ALL survival was documented for the population with Social Security benefits and in multisector cohorts during the same period ( 11 , 12 ).…”

“…In 2020, Seguro Popular was suddenly dissolved, and the established national drug procurement systems were rapidly dismantled. Since then, the Mexican health system has been in constant redesign ( 6 , 13 ). New models of care, health governance, and health financing are underway, but details on if, when, and how the health system will achieve new levels of system performance remain to be determined.…”